Novavax
NVAX
#5751
Rank
HK$8.73 B
Marketcap
HK$53.77
Share price
0.73%
Change (1 day)
-16.75%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of September 2025 : HK$9.18 Billion

According to Novavax's latest financial reports the company's total assets are HK$9.18 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$12.11 B-13.71%
2023-12-31HK$14.03 B-20.45%
2022-12-31HK$17.64 B-12.17%
2021-12-31HK$20.09 B63.78%
2020-12-31HK$12.26 B810.74%
2019-12-31HK$1.34 B-17.29%
2018-12-31HK$1.62 B-31.09%
2017-12-31HK$2.36 B-22.71%
2016-12-31HK$3.05 B2.19%
2015-12-31HK$2.99 B39.76%
2014-12-31HK$2.14 B17.42%
2013-12-31HK$1.82 B129.83%
2012-12-31HK$0.79 B53.42%
2011-12-31HK$0.51 B-11.22%
2010-12-31HK$0.58 B-12.25%
2009-12-31HK$0.66 B12.1%
2008-12-31HK$0.59 B-16.81%
2007-12-31HK$0.71 B-24.91%
2006-12-31HK$0.94 B44.89%
2005-12-31HK$0.65 B7.94%
2004-12-31HK$0.60 B-7.09%
2003-12-31HK$0.65 B45.46%
2002-12-31HK$0.44 B-14.31%
2001-12-31HK$0.52 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
HK$1.82 B-80.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$27.18 B 196.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$11.36 B 23.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
HK$3.47 B-62.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$890.67 B 9,600.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$1.624 T 17,590.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$834.89 B 8,993.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
HK$68.66 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$641.68 B 6,888.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
HK$5.04 B-45.04%๐Ÿ‡บ๐Ÿ‡ธ USA